Devroe Eric Insider Trading Activity (ACRV)

Summary

Updated Jul 16, 2026

Devroe Eric has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $17K.

Profile

Eric Devroe is the Chief Operating Officer of Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology with a proteomics-based patient responder identification platform. SEC filings through 2026-01-15 list him as COO with five total filings and no reported insider purchases or sales, indicating ongoing executive leadership and oversight of corporate operations at Acrivon during public reporting.

Role	Insider
Notability	50/100

Board memberships

Acrivon Therapeutics, Inc.

Awards & honors

Listed as COO in SEC filings for Acrivon Therapeutics
Overseen operational aspects of a clinical-stage oncology company during public reporting
contributed to corporate governance and operational continuity within SEC disclosures

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-05-20	ACRV	Acrivon Therapeutics, Inc.	A — Grant or award	73.0K	$0.00
2026-05-18	ACRV	Acrivon Therapeutics, Inc.	F — Tax withholding / forfeiture	613	$1.92	$1K
2026-02-18	ACRV	Acrivon Therapeutics, Inc.	F — Tax withholding / forfeiture	723	$1.63	$1K
2026-01-15	ACRV	Acrivon Therapeutics, Inc.	P — Open-market purchase	10.0K	$1.72	$17K
2025-08-14	ACRV	Acrivon Therapeutics, Inc.	F — Tax withholding / forfeiture	613	$1.39	$852
2024-11-18	ACRV	Acrivon Therapeutics, Inc.	F — Tax withholding / forfeiture	613	$7.92	$5K

Frequently Asked Questions

Who is Devroe Eric?

How many SEC Form 4 filings has Devroe Eric submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has Devroe Eric been buying or selling stock?

Recorded transactions: 1 open-market purchases ($17K) and 0 open-market sales () across all tracked filings.

Where can I see all of Devroe Eric's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Devroe Eric — SEC Form 4 Insider Trading Activity